The Center for Multiple Myeloma Nanotherapy (CMMN) is an interdisciplinary program that spans across the Washington University campus, its medical school and the Siteman Cancer Center. Leaders of CMMN are:
Program Director and Principal Investigator
Samuel Achilefu, PhD
Professor of Radiology, Biochemistry and Molecular Biophysics, & Biomedical Engineering
Achilefu is a pioneer in the development of molecular imaging probes and nanomaterials for imaging and treatment of cancer. He currently leads the translation of innovative imaging technologies and molecular probes from bench to bedside.
Co-Director and Principal Investigator
Gregory Lanza, MD
Professor of Medicine and Biomedical Engineering
Lanza is a distinguished leader in the development and translation of nanomaterials to the clinic. He has extensive experience in the practice of medicine, nanomedicine research and development, and pharmaceutical development in large industry as well as small biotechnology start-ups.